Literature DB >> 30082859

Beta cell preservation in patients with type 1 diabetes.

Tony K T Lam1,2,3,4, David Z I Cherney5,6,7,8,9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30082859     DOI： 10.1038/s41591-018-0144-1

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  3 in total

Review 1.  Thioredoxin-Interacting Protein as a Novel Potential Therapeutic Target in Diabetes Mellitus and Its Underlying Complications.

Authors:  Dawit Zewdu Wondafrash; Asmelash Tesfay Nire'a; Gebrehiwot Gebremedihn Tafere; Desilu Mahari Desta; Demoze Asmerom Berhe; Kaleab Alemayehu Zewdie
Journal:  Diabetes Metab Syndr Obes       Date:  2020-01-07       Impact factor: 3.168

Review 2.  From Disease and Patient Heterogeneity to Precision Medicine in Type 1 Diabetes.

Authors:  Nicoline H M den Hollander; Bart O Roep
Journal:  Front Med (Lausanne)       Date:  2022-07-12

3.  Advances and complications of regenerative medicine in diabetes therapy.

Authors:  Olga Brovkina; Erdem Dashinimaev
Journal:  PeerJ       Date:  2020-09-08       Impact factor: 2.984
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.